Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates fluorogenic monitoring of autophagy and inducible protein clearance in cellular models, highlighting a versatile platform for targeted degradation therapies.
Macroautophagy is central to cellular homeostasis and emerges as a promising avenue for targeted degradation. However, there is still a lack of efficient approaches allowing for visualizing macroautophagic flux and degradation. Here we develop a semi-synthetic LC3-interacting degrader (SLID) that enables fluorogenic imaging of macroautophagic activities and visualization of targeted degradation. SLID is engineered by fusing LC3-interacting regions (LIRs) to a self-labeling tag and an oligomeric motif, with the LIRs for binding to autophagosomes, the oligomeric motif for enhancing the binding, and the self-labeling tag for visualizing autophagosome formation using a pH indicator. SLID is further coupled to an antibody domain through a dimerization-induced proximity system, allowing chemically inducible degradation of target proteins. We show that this SLID platform permits efficient degradation of diverse target proteins such as disease-associated aggregation-prone proteins and phase-separated condensates. SLID also reveals elevated macroautophagic activities in senescent cells, and is repurposed for inducing senescent cell apoptosis via degradation of pro-survival and anti-apoptotic proteins. Our study highlights the great promise of SLID as a versatile tool for studying macroautophagy and targeted protein degradation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: